SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,909.68 -325.78
( -0.42%)

Global Indices

Nasdaq

53,487.79 123.39
(0.23%)

Dow Jones

7,729.14 16.38
(0.21%)

Hang Seng

65,335.94 -2,124.79
(-3.15%)

Nikkei 225

10,747.45 19.41
(0.18%)

Forex

USD-INR

95.60 0.07
(0.07%)

EUR-INR

110.76 0.24
(0.21%)

GBP-INR

129.56 0.29
(0.22%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Emcure Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

544210

INE168P01015

195.6288102

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EMCURE

43.42

35938.7

EPS(TTM)

Face Value()

Div & Yield %

43.64

0.19

Back

Anand Projects reports consolidated net loss of Rs 0.06 crore in the June 2026 quarter

Jul 28,2026

Net Loss of Anand Projects reported to Rs 0.06 crore in the quarter ended June 2026 as against net loss of Rs 0.08 crore during the previous quarter ended June 2025. Sales declined 16.67% to Rs 0.25 crore in the quarter ended June 2026 as against Rs 0.30 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	0.25	0.30	-17
OPM %	-28.00	-33.33	-
PBDT	-0.07	-0.09	22
PBT	-0.07	-0.09	22
NP	-0.06	-0.08	25

76,909.68 -325.78 ( -0.42%)

53,487.79 123.39 (0.23%)

7,729.14 16.38 (0.21%)

65,335.94 -2,124.79 (-3.15%)

10,747.45 19.41 (0.18%)

95.60 0.07 (0.07%)

110.76 0.24 (0.21%)

129.56 0.29 (0.22%)

0.60 0.00 (0.12%)